Zevra Therapeutics (ZVRA) Shareholder's Equity Growth (3y) (2017 - 2026)
Zevra Therapeutics (ZVRA) Shareholder's Equity Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Zevra Therapeutics |
796.95 Mn |
596.33 Mn |
34.30 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
51.43% |
| Dec 31, 2025 |
27.21% |
| Sep 30, 2025 |
12.39% |
| Mar 31, 2025 |
-54.39% |
| Dec 31, 2024 |
-26.93% |
| Sep 30, 2024 |
-19.09% |
| Jun 30, 2024 |
-37.12% |
| Mar 31, 2024 |
-16.63% |
| Dec 31, 2023 |
43.12% |
| Sep 30, 2023 |
44.02% |
| Jun 30, 2023 |
43.20% |
| Mar 31, 2023 |
42.00% |
| Dec 31, 2022 |
44.37% |
| Sep 30, 2022 |
49.30% |
| Mar 31, 2022 |
98.13% |
| Dec 31, 2021 |
52.22% |
| Sep 30, 2021 |
50.10% |
| Jun 30, 2021 |
52.75% |
| Mar 31, 2021 |
45.14% |
| Dec 31, 2020 |
-4.91% |
